Interestingly, we did not notice pathological cardiac hypertrophy or diastolic dysfunction in association with the less robustly activated transcriptome in mNrf2-TG mice, suggesting that the expression of full-length Nrf2 is tightly under the control of its repressor, Keap1. The gene discussed is NFE2L2; the disease is cardiac hypertrophy.